Gilead Funds BRG Study Taking Aim at 340B Grantees
Gilead Funds BRG Study Taking Aim at 340B Grantees On May 22, 2023, the Berkeley Research Group (BRG) published a “study” titled “Federal Grantee Clinics and the 340B Drug…
Pharmaceutical Manufacturer 340B Price Restriction Chart Updated
Pharmaceutical Manufacturer 340B Price Restriction Policies and Exemptions Summary
RWC-340B Opposes Medicaid Pharmacy Budget Gimmick
View and share the PDF Version Here. PRESS STATEMENT: FOR IMMEDIATE RELEASE National Ryan White Clinic Organization Calls on State of New York to Reverse Medicaid Pharmacy Budget Gimmick, Support…
RWC-340B | 340B Statement of Principles
View as PDF 340B STATEMENT OF PRINCIPLES RWC-340B is a national association of HIV/AIDS clinics and service providers that receive support under the Ryan White Comprehensive AIDS Resources…
RWC-340B Statement Regarding ASAP 340B Core Principles
RWC-340B Statement Regarding ASAP 340B Core Principles After carefully considering the ASAP 340B discussion draft and accompanying materials, RWC-340B is opposed to the proposal as written. We are especially…
Pharmaceutical Manufacturer 340B Price Restriction Policies and Exemptions Summary Chart Updated
See RWC-340B’s updated chart below: (Updated 02.22.23) Pharmaceutical Manufacturer 340B Price Restriction Policies and Exemptions Summary (D1049682)
North Texas HIV clinics face near $20M hit due to new PrEP reimbursement policy
RWC-340B Members, Dr. John Carlo of Prism Health and David Poole of AHF, are quoted throughout the linked article, displaying the many challenges faced by clinics navigating changes in PrEP…
RWC-340B Webinar Replay: 340B Primer
Explore the fundamentals of 340B with experts from the field. Key Topics: -History and purpose of the 340B program -How 340B program acts as a taxpayer relief program -340B eligibility…
RWC-340B Releases Analysis Warning Federal and State Policymakers of Drug Industry Disinformation Campaign
RWC-340B releases analysis warning federal and state policymakers of drug industry disinformation campaign. “RWC-340B will not stand idle while the pharmaceutical industry attacks safety net providers in the 340B…
RWC-340B Submits Comments to HRSA regarding 340B Registration Changes
RWC-340B President, Shannon Stephenson, submitted comments to HRSA in response to the Information Collection Request (ICR), issued by the Health Resources and Services Administration (HRSA). In the submission, RWC-340B made…